000
| 02643nam 2200325za 4500 |
---|
001 | 9.826231 |
---|
003 | CaOODSP |
---|
005 | 20221107144534 |
---|
007 | cr ||||||||||| |
---|
008 | 161024t20162015onc ob f000 0 eng d |
---|
020 | |z978-1-100-24887-5 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aHP40-77/2015E-PDF|zHP40-77/2014E-PDF |
---|
245 | 10|aTransfusion Error Surveillance System (TESS) |h[electronic resource] : |b2012-2013 report. |
---|
246 | 17|aTransfusion Error Surveillance System : |b2012-2013 report |
---|
260 | |aOttawa : |bPublic Health Agency of Canada, Centre for Communicable Diseases and Infection Control, |c2016, c2015. |
---|
300 | |aii, 39 p. |
---|
500 | |aIssued also in French under title: Système de surveillance des erreurs transfusionnelles (SSET) : rapport 2012-2013. |
---|
500 | |aIncorrect catalogue number (HP40-77/2014E-PDF) and ISBN (978-1-100-24887-5) printed in this publication. |
---|
504 | |aIncludes bibliographic references (p. 31). |
---|
520 | |a"Blood transfusions are an important component of Canada’s health care system. Although Canada has one of the safest blood systems in the world, transfusion-related errors can occur at various points in the transfusion chain, which encompasses any point in the collection, labelling, testing, storing, handling, transfusion, etc. of blood components and products and during the collection, labelling, testing, storing and handling of pre-transfusion patient samples. Transfusion-related errors may occur in either clinical or laboratory settings and may result in ABO incompatibilities, administrative delays, product wastage, inappropriate transfusions and the possible need for sample re-collection. Limiting opportunities for transfusion errors is therefore an important aspect of public health safety. This report offers an analysis of the Transfusion Error Surveillance System (TESS) data reported from 2012 to 2013. Findings are presented for all transfusion-related errors, including errors that were detected prior to blood transfusion as well as errors detected during and after blood transfusion”--Executive summary. |
---|
692 | 07|2gccst|aBlood supply |
---|
692 | 07|2gccst|aInfected blood |
---|
692 | 07|2gccst|aControl |
---|
710 | 2 |aPublic Health Agency of Canada. |
---|
710 | 2 |aCentre for Communicable Diseases and Infection Control (Canada) |
---|
775 | 08|tSystème de surveillance des erreurs transfusionnelles (SSET) |w(CaOODSP)9.677224 |
---|
794 | |tTransfusion error surveillance system (TESS) : |w(CaOODSP)9.896992 |
---|
856 | 40|qPDF|s1.90 MB|uhttps://publications.gc.ca/collections/collection_2016/aspc-phac/HP40-77-2015-eng.pdf |
---|